Literature DB >> 25118275

PIP5K1α inhibition as a therapeutic strategy for prostate cancer.

Justin M Drake1, Jiaoti Huang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25118275      PMCID： PMC4156720          DOI： 10.1073/pnas.1413363111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  21 in total

1.  Regulation of C. elegans life-span by insulinlike signaling in the nervous system.

Authors:  C A Wolkow; K D Kimura; M S Lee; G Ruvkun
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

3.  A phase II study of perifosine in androgen independent prostate cancer.

Authors:  Edwin M Posadas; James Gulley; Philip M Arlen; Alisa Trout; Howard L Parnes; John Wright; Min-Jung Lee; Eun Joo Chung; Jane B Trepel; Alex Sparreboom; Clara Chen; Elizabeth Jones; Seth M Steinberg; Andrew Daniels; William D Figg; William L Dahut
Journal:  Cancer Biol Ther       Date:  2005-10-01       Impact factor: 4.742

Review 4.  Targeting the PI3K signaling pathway in cancer.

Authors:  Kwok-Kin Wong; Jeffrey A Engelman; Lewis C Cantley
Journal:  Curr Opin Genet Dev       Date:  2009-12-16       Impact factor: 5.578

5.  The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial.

Authors:  Karen G Chee; Jeff Longmate; David I Quinn; Gurkamal Chatta; Jacek Pinski; Przemyslaw Twardowski; Chong-Xian Pan; Angelo Cambio; Christopher P Evans; David R Gandara; Primo N Lara
Journal:  Clin Genitourin Cancer       Date:  2007-12       Impact factor: 2.872

6.  The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.

Authors:  Julius Semenas; Andreas Hedblom; Regina R Miftakhova; Martuza Sarwar; Rikard Larsson; Liliya Shcherbina; Martin E Johansson; Pirkko Härkönen; Olov Sterner; Jenny L Persson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

7.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

8.  Identification of a cell of origin for human prostate cancer.

Authors:  Andrew S Goldstein; Jiaoti Huang; Changyong Guo; Isla P Garraway; Owen N Witte
Journal:  Science       Date:  2010-07-30       Impact factor: 47.728

9.  mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.

Authors:  Kathryn E O'Reilly; Fredi Rojo; Qing-Bai She; David Solit; Gordon B Mills; Debra Smith; Heidi Lane; Francesco Hofmann; Daniel J Hicklin; Dale L Ludwig; Jose Baselga; Neal Rosen
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

10.  Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.

Authors:  Brett S Carver; Caren Chapinski; John Wongvipat; Haley Hieronymus; Yu Chen; Sarat Chandarlapaty; Vivek K Arora; Carl Le; Jason Koutcher; Howard Scher; Peter T Scardino; Neal Rosen; Charles L Sawyers
Journal:  Cancer Cell       Date:  2011-05-17       Impact factor: 31.743
View more
  7 in total

1.  FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.

Authors:  Per Flodbring Larsson; Richard Karlsson; Martuza Sarwar; Regina Miftakhova; Tianyan Wang; Azharuddin Sajid Syed Khaja; Julius Semenas; Sa Chen; Andreas Hedblom; Amjad Ali; Kristina Ekström-Holka; Athanasios Simoulis; Anjani Kumar; Anette Gjörloff Wingren; Brian Robinson; Sun Nyunt Wai; Nigel P Mongan; David M Heery; Daniel Öhlund; Thomas Grundström; Niels Ødum; Jenny L Persson
Journal:  Mol Oncol       Date:  2022-01-23       Impact factor: 7.449

2.  Membrane Recognition and Binding by the Phosphatidylinositol Phosphate Kinase PIP5K1A: A Multiscale Simulation Study.

Authors:  Sarah-Beth T A Amos; Antreas C Kalli; Jiye Shi; Mark S P Sansom
Journal:  Structure       Date:  2019-06-13       Impact factor: 5.871

Review 3.  Mechanisms of Taxane Resistance.

Authors:  Sara M Maloney; Camden A Hoover; Lorena V Morejon-Lasso; Jenifer R Prosperi
Journal:  Cancers (Basel)       Date:  2020-11-10       Impact factor: 6.639

4.  Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration-resistant prostate cancer.

Authors:  Julius Semenas; Tianyan Wang; Azharuddin Sajid Syed Khaja; Akm Firoj Mahmud; Athanasios Simoulis; Thomas Grundström; Maria Fällman; Jenny L Persson
Journal:  Mol Oncol       Date:  2020-12-16       Impact factor: 6.603

5.  PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer.

Authors:  Tianyan Wang; Martuza Sarwar; Jonathan B Whitchurch; Hilary M Collins; Tami Green; Julius Semenas; Amjad Ali; Christopher J Roberts; Ryan D Morris; Madlen Hubert; Sa Chen; Zahra El-Schich; Anette G Wingren; Thomas Grundström; Richard Lundmark; Nigel P Mongan; Lena Gunhaga; David M Heery; Jenny L Persson
Journal:  Front Cell Dev Biol       Date:  2022-03-21

6.  Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells.

Authors:  Martuza Sarwar; Julius Semenas; Regina Miftakhova; Athanasios Simoulis; Brian Robinson; Anette Gjörloff Wingren; Nigel P Mongan; David M Heery; Heather Johnsson; Per-Anders Abrahamsson; Nishtman Dizeyi; Jun Luo; Jenny L Persson
Journal:  Oncotarget       Date:  2016-09-27

7.  An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome.

Authors:  Yingxin Han; Liyan Ji; Yanfang Guan; Mengya Ma; Pansong Li; Yinge Xue; Yinxin Zhang; Wanqiu Huang; Yuhua Gong; Li Jiang; Xipeng Wang; Hong Xie; Boping Zhou; Jiayin Wang; Junwen Wang; Jinghua Han; Yuliang Deng; Xin Yi; Fei Gao; Jian Huang
Journal:  Clin Transl Med       Date:  2021-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.